查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576939

数位/电力血压计:市场洞察·竞争环境·市场预测 (～2030年)

Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

数位/电子血压计市场规模预计将从 2023 年的 9.7778 亿美元成长到 2030 年的 17.8388 亿美元，预计 2024-2030 年的复合年增长率将达到 10.57%。

高血压和其他心血管疾病发生率的增加刺激了对定期血压监测的需求，推动了数位/电子血压计市场的发展。这些疾病通常需要持续监测来管理风险，促使对家庭设备的依赖增加。健康意识的提高正在推动定期监测，数位血压计因其易用性和便携性而越来越受欢迎。此外，蓝牙连接和智慧型手机整合等持续的技术创新正在增加其对消费者和医疗保健提供者的吸引力，进一步推动市场成长。这些扩大的治疗选择和日益激烈的竞争预计将改善患者的治疗效果并推动 2024 年至 2030 年的市场成长。

数位/电动血压计市场动态：

根据世界卫生组织 (WHO) 2023 年的最新数据，全球估计有 12.8 亿 30 岁至 79 岁的成年人患有高血压，其中大多数（三分之二）患有低血压。收入国家。据估计，有 46% 的成人高血压患者不知道自己的症状，只有不到一半 (42%) 得到诊断和治疗。

根据英国心臟基金会2024年的最新数据，全球约有6.2亿人（约13人中就有1人）患有心臟和循环系统疾病。此外，同一数据显示，2021年，欧洲有1亿人患有心臟和循环系统疾病，亚洲和澳洲有3.4亿人患有心臟病和循环系统疾病。此外，缺血性冠状动脉心臟病是全世界最常诊断的疾病，影响估计2亿人。约 1.1 亿男性和 8,000 万名女性受到影响。

高血压是多种心血管疾病的主要危险因素，包括心臟病、中风和心臟衰竭，因此需要定期准确监测血压，以有效控制这些疾病的发生。因此，数位血压计具有用户友好的介面、便携性以及无需大量医疗培训即可提供可靠读数的能力，是患者和医疗保健提供者的必备工具。

除上述因素外，数位/电子血压计领域的技术进步，例如开发新技术以提高诊断准确性，预计也将有助于数位/电子血压计市场的成长。

本报告提供全球数位/电力血压计的市场调查，提供市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 数位/电力血压计市场:简介

第2章 数位/电力血压计市场:摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 数位/电力血压计市场:主要要素分析

  • 推动市场要素
    • 高血压、心血管疾病和其他循环系统疾病的发生率增加
    • 提高健康意识
    • 数位/电子血压计领域的技术进步
  • 阻碍市场要素·课题
    • 有关数位/电子血压计的准确性问题
    • 需要不断重新校准血压计
  • 市场机会
    • 穿戴式装置的出现/越来越多地转向远距病患监护

第6章 数位/电力血压计市场:波特的五力分析

第7章 数位/电力血压计市场:市场评估

  • 各产品类型
    • 上臂
    • 手腕
  • 各技术
    • 完全自动
    • 半自动
  • 可携带性
    • 可携式
    • 非可携式
  • 各终端用户
    • 医院·诊所
    • 门诊病人诊疗中心
    • 居家照护
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 数位/电力血压计市场:企业·产品简介

  • OMRON Healthcare, Inc.
  • Hill-Rom Services, Inc.
  • A&D Company Limited
  • SunTech Medical, Inc.
  • American Diagnostic Corporation
  • Withings
  • General Electric Company
  • Microlife Corporation
  • GF Health Products, Inc.
  • Spacelabs Healthcare
  • Rudolf Riester GmbH
  • Contec Medical Systems Co., Ltd.
  • ARCHOS(TM)
  • Panasonic Corporation
  • Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
  • ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
  • BOSCH + SOHN GmbH u. Co. KG.
  • Beijing Choice Electronic Tech Co., Ltd.
  • Koninklijke Philips N.V.
  • SPENGLER HOLTEX Group

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明·咨询方式

Product Code: DIMDCL0246

Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals & Clinics, Ambulatory Care Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of hypertension, other circulatory system disorders, and growing technological advancements in the field of digital/electrical sphygmomanometer.

The global digital/electrical sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030. The increasing incidence of hypertension and other circulatory disorders has fueled the demand for regular blood pressure monitoring, driving the market for digital/electrical sphygmomanometers. These disorders often require continuous monitoring to manage risks, which increases reliance on home-use devices. Increased health awareness is boosting regular monitoring, making digital sphygmomanometers popular for their ease of use and portability. Additionally, continuous innovations, such as bluetooth connectivity and smartphone integration, are enhancing their appeal to both consumers and healthcare providers, further propelling market growth. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

Digital/Electrical Sphygmomanometer Market Dynamics:

As per the latest data provided by World Health Organization (2023), an estimated 1.28 billion adults aged 30-79 years worldwide had hypertension, with most (two-thirds) residing in low- and middle-income countries. An estimated 46% of adults with hypertension were unaware of their condition, and less than half (42%) had been diagnosed and treated.

According to a recent data provided by British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, lived with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, was the most commonly diagnosed worldwide, affected an estimated 200 million people globally. Approximately 110 million men and 80 million women were affected. Additionally, around 56 million women and 45 million men were stroke survivors. It was estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed.

As hypertension is a major risk factor for various cardiovascular conditions, including heart attacks, strokes, and heart failure, there is an increasing need for regular and accurate monitoring of blood pressure to manage these diseases effectively. Thus, digital sphygmomanometers, with their user-friendly interfaces, portability, and ability to provide reliable readings without requiring extensive medical training, have become indispensable tools for both patients and healthcare providers thereby escalating the overall market of digital/electrical sphygmomanometer across the globe.

Along with the factors mentioned above, technological advancements in the field of digital/electrical sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the digital/electrical sphygmomanometer market. For instance, in January 2022, Aktiia announced a landmark hypertension trial in the United States in collaboration with a top US hypertension center, for its world's 24/7 blood pressure monitor, which automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.

However, digital/electrical sphygmomanometer being very sensitive due to which body movements affect its accuracy and the need for continuous recalibration of the devices may be certain limiting factors of the digital/electrical sphygmomanometer market growth.

Digital/Electrical Sphygmomanometer Market Segment Analysis:

Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals & Clinics, Ambulatory Care Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall digital/electrical sphygmomanometer market, the wrist type digital/electrical sphygmomanometer are expected to hold the largest share in the year 2023. Wrist-worn digital/electrical sphygmomanometers are playing a significant role in boosting the overall market for blood pressure monitoring devices. Their unique design and user-friendly features cater to a growing demand for convenience, portability, and real-time health monitoring, contributing to their increasing popularity among consumers and healthcare providers alike.

Additionally, the primary advantages of wrist-worn sphygmomanometers is their portability. Wrist-worn models are compact and lightweight, making them ideal for users who need to monitor their blood pressure regularly while on the go. This convenience appeals to a broad range of consumers, including those who travel frequently or have busy lifestyles, thereby expanding the market reach of digital sphygmomanometers. These devices are typically easier to position and operate than their upper-arm counterparts, which can be especially beneficial for elderly users or individuals with limited mobility. The simplicity of wrist-worn sphygmomanometers encourages more frequent monitoring, aligning with the growing trend of proactive health management. As people become more aware of the importance of tracking their blood pressure regularly to prevent or manage conditions like hypertension, the demand for user-friendly, accessible devices increases, further boosting the market.

Furthermore, the technological advancements in wrist-worn digital sphygmomanometers are also contributing to their rising popularity. Modern devices often feature integration with smartphones and other digital health platforms, allowing users to easily track and analyze their blood pressure data over time. This ability to monitor trends and share data with healthcare providers enhances the utility of wrist-worn devices, making them an attractive option for tech-savvy consumers and those managing chronic conditions. For instance, in June 2022, LiveMetric announced the launch of LiveOne, the world's first 510(k) FDA-cleared nano-sensor technology for continuous blood pressure monitoring. This wrist-worn, cuff-free device provided real-time measurements every 10 seconds, improving care for hypertension and cardiovascular patients. Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global digital/electrical sphygmomanometer market during the forecast period.

North America is expected to dominate the overall digital/electrical sphygmomanometer market:

Among all the regions, North America is expected to hold the largest share in the global digital/electrical sphygmomanometer market in 2023. Owing to significant growth factors such as hypertension, cardiovascular diseases. Additionally, increasing health awareness, rising government initiatives, and increasing product launches and product approvals are expected to aid in the growth of the North American digital/electrical sphygmomanometer market during the forecast period from 2024 to 2030.

According to the latest data provided by the Centre for Disease Control and Prevention (2023), approximately, 48.1% population of adults age 18 and older in the United States are living with hypertension. Additionally, as per the recent data from the Centers for Disease Control and Prevention (2024), approximately 4.9% of adults were diagnosed with coronary heart disease in 2022. Furthermore, by 2023, an estimated 12.1 million individuals in the United States were projected to have atrial fibrillation. Additionally, each year, over 795,000 people in the U.S. experience a stroke, with around 610,000 of these being first-time strokes. Notably, nearly 185,000 of these strokes, or about one in four, occur in individuals who have previously had a stroke. With hypertension being a critical risk factor for cardiovascular conditions, including heart attacks, strokes, and heart failure, there is an escalating need for reliable and consistent blood pressure monitoring. Digital sphygmomanometers, with their user-friendly design, portability, and precision, have become indispensable for effective disease management. This trend is accelerating the growth of the digital/electrical sphygmomanometers across the region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for digital/electrical sphygmomanometer. For instance, in March 2021, Qardio, Inc. announced the US Food and Drug Administration (FDA) 510k clearance for its QardioCore ambulatory ECG device.

Therefore, the above-mentioned factors are expected to bolster the growth of the digital/electrical sphygmomanometer market in the North America during the forecast period.

Digital/Electrical Sphygmomanometer Market Key Players:

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group, and others.

Recent Developmental Activities in the Digital/Electrical Sphygmomanometer Market:

  • In January 2024, Nanowear announced the FDA 510(k) clearance for SimpleSense-BP, AI-enabled continuous blood pressure monitoring and for hypertension diagnostic management.
  • In August 2023, Corsano Health launched CardioWatch EU-MDR , a cuffless blood pressure monitor.
  • In September 2022, Gramin received FDA clearance for smart BPM Smart Blood Pressure Monitor.
  • In August 2022, Sensifree Ltd. Received CE certificate for SentiCor-100(R) in compliance with the new EU MDR.
  • In February 2022, Abbott announced the US Food and Drug Administration (FDA) approval of an expanded indication for its CardioMEMS(TM) HF System to support the care of more people living with heart failure. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.

Key Takeaways From the Digital/Electrical Sphygmomanometer Market Report Study:

  • Market size analysis for current digital/electrical sphygmomanometer size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the digital/electrical sphygmomanometer market.
  • Various opportunities available for the other competitors in the digital/electrical sphygmomanometer market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current digital/electrical sphygmomanometer market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for digital/electrical sphygmomanometer market growth in the coming future?

Target Audience who can be Benefited From This Digital/Electrical Sphygmomanometer Market Report Study:

  • Digital/electrical sphygmomanometer product providers
  • Research organizations and consulting companies
  • Digital/electrical sphygmomanometer -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in digital/electrical sphygmomanometer
  • Various end-users who want to know more about the digital/electrical sphygmomanometer market and the latest technological developments in the digital/electrical sphygmomanometer market.

Frequently Asked Questions for the Digital/Electrical Sphygmomanometer Market:

1. What are digital/electrical sphygmomanometer?

  • Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). These devices are of three types mainly mercury sphygmomanometers, an aneroid sphygmomanometer, and electronic/digital sphygmomanometer.

2. What is the market for digital/electrical sphygmomanometer?

  • The global digital/electrical sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030.

3. What are the drivers for the digital/electrical sphygmomanometer market?

  • The rising incidence of hypertension and other circulatory system disorders has driven demand for accurate, user-friendly blood pressure monitors. Increased health awareness is boosting regular monitoring, making digital sphygmomanometers popular for their ease of use and portability. Additionally, continuous innovations, such as bluetooth connectivity and smartphone integration, are enhancing their appeal to both consumers and healthcare providers, further propelling market growth. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

4. Who are the key players operating in the digital/electrical sphygmomanometer market?

  • Some of the key market players operating in the digital/electrical sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd., Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

5. Which region has the highest share in the digital/electrical sphygmomanometer market?

  • Among all the regions, North America is expected to hold the largest share in the global digital/electrical sphygmomanometer market in 2023. Owing to significant growth factors such as hypertension, cardiovascular diseases, increasing health awareness, rising government initiatives, and increased government product regulations are expected to aid in the growth of the North American digital/electrical sphygmomanometer market during the forecast period from 2024 to 2030.

Table of Contents

1. Digital/Electrical Sphygmomanometer Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Digital/Electrical Sphygmomanometer Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Digital/Electrical Sphygmomanometer Market Key Factors Analysis

  • 5.1. Digital/Electrical Sphygmomanometer Market Drivers
    • 5.1.1. Increasing incidence of hypertension, cardiovascular diseases, and other circulatory system disorders
    • 5.1.2. Increasing awareness for health
    • 5.1.3. Growing technological advancements in the field of digital/electrical sphygmomanometer
  • 5.2. Digital/Electrical Sphygmomanometer Market Restraints and Challenges
    • 5.2.1. Accuracy concerns related to digital/electrical sphygmomanometer
    • 5.2.2. Need for continuous recalibration of sphygmomanometer devices
  • 5.3. Digital/Electrical Sphygmomanometer Market Opportunities
    • 5.3.1. Increase in shift toward remote patient monitoring, combined with the emergence of wearable devices

6. Digital/Electrical Sphygmomanometer Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Digital/Electrical Sphygmomanometer Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Upper Arm
    • 7.1.2. Wrist Type
  • 7.2. By Technology
    • 7.2.1. Full-Automatic
    • 7.2.2. Semi-Automatic
  • 7.3. By Portability
    • 7.3.1. Portable
    • 7.3.2. Non-Portable
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Care Centers
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.1.2. Canada Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.1.3. Mexico Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.2. Germany Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.3. United Kingdom Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.4. Italy Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.5. Spain Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.6. Rest of Europe Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.2. Japan Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.3. India Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.4. Australia Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.5. South Korea Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.4.2. Africa Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.4.3. South America Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)

8. Digital/Electrical Sphygmomanometer Market Company and Product Profiles

  • 8.1. OMRON Healthcare, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Hill-Rom Services, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. A&D Company Limited
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. SunTech Medical, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. American Diagnostic Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Withings
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. General Electric Company
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Microlife Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. GF Health Products, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Spacelabs Healthcare
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Rudolf Riester GmbH
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Contec Medical Systems Co., Ltd.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. ARCHOS(TM)
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Panasonic Corporation
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. BOSCH + SOHN GmbH u. Co. KG.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Beijing Choice Electronic Tech Co., Ltd.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Koninklijke Philips N.V.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. SPENGLER HOLTEX Group
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
  • Table 3: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
  • Table 4: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
  • Table 5: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
  • Table 6: Digital/Electrical Sphygmomanometer Market in Global by End-User (2021-2030)
  • Table 7: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
  • Table 8: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
  • Table 9: Digital/Electrical Sphygmomanometer Market in the United States (2021-2030)
  • Table 10: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
  • Table 11: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
  • Table 12: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
  • Table 13: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
  • Table 14: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
  • Table 15: Digital/Electrical Sphygmomanometer Market in United Kingdom (2021-2030)
  • Table 16: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
  • Table 17: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
  • Table 18: Digital/Electrical Sphygmomanometer Market in the Rest of Europe (2021-2030)
  • Table 19: Digital/Electrical Sphygmomanometer Market in Asia-Pacific (2021-2030)
  • Table 20: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
  • Table 21: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
  • Table 22: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
  • Table 23: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
  • Table 24: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
  • Table 25: Digital/Electrical Sphygmomanometer Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Digital/Electrical Sphygmomanometer Market in the Rest of the World (2021-2030)
  • Table 27: Digital/Electrical Sphygmomanometer Market in the Middle East (2021-2030)
  • Table 28: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
  • Table 29: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
  • Figure 3: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
  • Figure 4: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
  • Figure 5: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
  • Figure 6: Digital/Electrical Sphygmomanometer Market in Global by End-User (2021-2030)
  • Figure 7: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
  • Figure 8: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
  • Figure 9: Digital/Electrical Sphygmomanometer Market in the United States (2021-2030)
  • Figure 10: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
  • Figure 11: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
  • Figure 12: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
  • Figure 13: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
  • Figure 14: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
  • Figure 15: Digital/Electrical Sphygmomanometer Market in United Kingdom (2021-2030)
  • Figure 16: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
  • Figure 17: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
  • Figure 18: Digital/Electrical Sphygmomanometer Market in the Rest of Europe (2021-2030)
  • Figure 19: Digital/Electrical Sphygmomanometer Market in Asia-Pacific (2021-2030)
  • Figure 20: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
  • Figure 21: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
  • Figure 22: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
  • Figure 23: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
  • Figure 24: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
  • Figure 25: Digital/Electrical Sphygmomanometer Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Digital/Electrical Sphygmomanometer Market in the Rest of the World (2021-2030)
  • Figure 27: Digital/Electrical Sphygmomanometer Market in the Middle East (2021-2030)
  • Figure 28: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
  • Figure 29: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis